Expert Advice 16 Feb 2023
Five things you need to know about using CRISPR/Cas9 commercially
By Michael Arciero, vice president of intellectual property and corporate development, ERS Genomics Michael Arciero, ERS Genomics CRISPR/Cas9 gene editing technology is a patented invention, so any commercial use requires…